Trastuzumab is a humanized IgG1 monoclonal antibody designed to treat HER2-positive metastatic breast cancer, HER2-positive gastric or gastroesophageal junction adenocarcinoma, and certain HER2-low advanced… Read more
Trastuzumab is a humanized IgG1 monoclonal antibody designed to treat HER2-positive metastatic breast cancer, HER2-positive gastric or gastroesophageal junction adenocarcinoma, and certain HER2-low advanced solid tumors. Within this category, researchers and pharmaceutical laboratories access high-quality reference standards, synthetic building blocks, and related impurities essential for comprehensive analytical testing and quality control. These materials, including specific impurities like Mal-PEG2-alcohol and key intermediates such as Fmoc-Val-Cit-PAB-OH or Fmoc-L-Val-OSu, are critical for method validation and structural characterization during the development and manufacturing of antibody-drug conjugates and similar biotherapeutics. By utilizing these precisely characterized compounds, analytical chemists can perform accurate impurity profiling and quantitative analysis using sophisticated techniques like high-performance liquid chromatography and mass spectrometry. These standards ensure that laboratory workflows meet strict regulatory requirements for purity, consistency, and safety assessment throughout the drug lifecycle.